These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25517032)

  • 1. Identification of biomarkers in cerebrospinal fluid and serum of multiple sclerosis patients by immunoproteomics approach.
    Colomba P; Fontana S; Salemi G; Barranca M; Lo Sicco C; Mazzola MA; Ragonese P; Savettieri G; De Leo G; Alessandro R; Duro G
    Int J Mol Sci; 2014 Dec; 15(12):23269-82. PubMed ID: 25517032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum and cerebrospinal fluid light neurofilaments and antibodies against them in clinically isolated syndrome and multiple sclerosis.
    Fialová L; Bartos A; Svarcová J; Zimova D; Kotoucova J; Malbohan I
    J Neuroimmunol; 2013 Sep; 262(1-2):113-20. PubMed ID: 23870535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-based profiling of cerebrospinal fluid within multiple sclerosis.
    Häggmark A; Byström S; Ayoglu B; Qundos U; Uhlén M; Khademi M; Olsson T; Schwenk JM; Nilsson P
    Proteomics; 2013 Aug; 13(15):2256-67. PubMed ID: 23696371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of biomarkers for multiple sclerosis as a neurodegenerative disorder.
    Ziemann U; Wahl M; Hattingen E; Tumani H
    Prog Neurobiol; 2011 Dec; 95(4):670-85. PubMed ID: 21524682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSF proteome analysis in clinically isolated syndrome (CIS): candidate markers for conversion to definite multiple sclerosis.
    Tumani H; Lehmensiek V; Rau D; Guttmann I; Tauscher G; Mogel H; Palm C; Hirt V; Suessmuth SD; Sapunova-Meier I; Ludolph AC; Brettschneider J
    Neurosci Lett; 2009 Mar; 452(2):214-7. PubMed ID: 19383442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus antibodies in serum and cerebrospinal fluid from multiple sclerosis, chronic inflammatory demyelinating polyradiculoneuropathy and amyotrophic lateral sclerosis.
    Nociti V; Frisullo G; Marti A; Luigetti M; Iorio R; Patanella AK; Bianco A; Tonali PA; Grillo RL; Sabatelli M; Batocchi AP
    J Neuroimmunol; 2010 Aug; 225(1-2):149-52. PubMed ID: 20510468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of complement proteins in cerebrospinal fluid from active multiple sclerosis patients.
    Li Y; Qin Z; Yang M; Qin Y; Lin C; Liu S
    J Cell Biochem; 2011 Jul; 112(7):1930-7. PubMed ID: 21445879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosis.
    Rentzos M; Cambouri C; Rombos A; Nikolaou C; Anagnostouli M; Tsoutsou A; Dimitrakopoulos A; Triantafyllou N; Vassilopoulos D
    J Neurol Sci; 2006 Feb; 241(1-2):25-9. PubMed ID: 16316662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein biomarkers for multiple sclerosis: semi-quantitative analysis of cerebrospinal fluid candidate protein biomarkers in different forms of multiple sclerosis.
    Avsar T; Korkmaz D; Tütüncü M; Demirci NO; Saip S; Kamasak M; Siva A; Turanli ET
    Mult Scler; 2012 Aug; 18(8):1081-91. PubMed ID: 22252467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Blood and cerebrospinal fluid biomarkers in MS/NMO].
    Nakatsuji Y
    Nihon Rinsho; 2014 Nov; 72(11):1970-5. PubMed ID: 25518379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid biomarkers of β-amyloid metabolism in multiple sclerosis.
    Augutis K; Axelsson M; Portelius E; Brinkmalm G; Andreasson U; Gustavsson MK; Malmeström C; Lycke J; Blennow K; Zetterberg H; Mattsson N
    Mult Scler; 2013 Apr; 19(5):543-52. PubMed ID: 23069872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis.
    Chowdhury SA; Lin J; Sadiq SA
    Arch Neurol; 2008 Feb; 65(2):232-5. PubMed ID: 18268193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis.
    Sharief MK; Hentges R
    N Engl J Med; 1991 Aug; 325(7):467-72. PubMed ID: 1852181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased CSF sulfatide levels and serum glycosphingolipid antibody levels in healthy siblings of multiple sclerosis patients.
    Haghighi S; Lekman A; Nilsson S; Blomqvist M; Andersen O
    J Neurol Sci; 2013 Mar; 326(1-2):35-9. PubMed ID: 23385003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of semaphorin 7A and ala-β-his-dipeptidase as biomarkers associated with the conversion from clinically isolated syndrome to multiple sclerosis.
    Cantó E; Tintoré M; Villar LM; Borrás E; Alvarez-Cermeño JC; Chiva C; Sabidó E; Rovira A; Montalban X; Comabella M
    J Neuroinflammation; 2014 Nov; 11():181. PubMed ID: 25406498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body fluid biomarkers in multiple sclerosis.
    Comabella M; Montalban X
    Lancet Neurol; 2014 Jan; 13(1):113-26. PubMed ID: 24331797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calprotectin levels in the cerebrospinal fluid reflect disease activity in multiple sclerosis.
    Berg-Hansen P; Vandvik B; Fagerhol M; Holmøy T
    J Neuroimmunol; 2009 Nov; 216(1-2):98-102. PubMed ID: 19800696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid proteomics in multiple sclerosis.
    Kroksveen AC; Opsahl JA; Guldbrandsen A; Myhr KM; Oveland E; Torkildsen Ø; Berven FS
    Biochim Biophys Acta; 2015 Jul; 1854(7):746-56. PubMed ID: 25526888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid and serum JC virus antibody detection in multiple sclerosis patients treated with natalizumab.
    Lin J; Bettin P; Lee JK; Ho JK; Sadiq SA
    J Neuroimmunol; 2013 Aug; 261(1-2):123-8. PubMed ID: 23800458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analyses of cerebrospinal fluid in the diagnosis and monitoring of multiple sclerosis.
    Awad A; Hemmer B; Hartung HP; Kieseier B; Bennett JL; Stuve O
    J Neuroimmunol; 2010 Feb; 219(1-2):1-7. PubMed ID: 19782408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.